Key result
10-week PACE-Life walking intervention increases weekly walking and reduces daily sitting in schizophrenia spectrum disorders.
Why the study?
Premature mortality in schizophrenia spectrum disorders is driven by chronic conditions, and while exercise improves health, scalable and accessible interventions remain limited.
Does the PACE-Life 10-week walking intervention improve physical activity in individuals with schizophrenia spectrum disorders?
Does the PACE-Life 10-week walking intervention improve physical activity in individuals with schizophrenia spectrum disorders?
A 10-week walking intervention in patients with schizophrenia spectrum disorders modestly improved self-reported physical activity and motivation, highlighting the feasibility of lifestyle interventions in this population.
Supports lifestyle interventions in schizophrenia; hypothesis-generating and should not yet change practice.
BACKGROUND: Premature mortality in individuals with schizophrenia spectrum disorders (SSDs) is largely due to high rates of chronic health conditions. Although exercise has been shown to improve health in this population, scalable and accessible interventions are limited. AIM: To examine the impact of Physical Activity Can Enhance Life (PACE-Life), a novel walking intervention, on physical activity, and on secondary outcomes of cardiorespiratory fitness (CRF), physical health, autonomous motivation, social support, and quality of life. METHOD: Sixteen individuals with SSDs were enrolled in a 10-week open trial. The intervention included walking groups, home-based walks, Fitbit use, and goal-setting and if-then plans. Within-group effect sizes were calculated to represent changes from baseline to post-test and 1-month follow-up. RESULTS: Participants increased self-reported weekly walking minutes and decreased daily hours spent sitting; however, Fitbit-recorded exercise behavior changed only minimally. There were also improvements in secondary outcomes including autonomous motivation and hip circumference. CRF improved only minimally, and findings were relatively unchanged with outliers removed from the full sample. CONCLUSIONS: This open trial demonstrates modest improvements in key parameters of exercise behavior and physical health from participating in PACE-Life. Future research should assess the efficacy of this intervention in a randomized controlled trial.
No takes yet. Share an insight, caveat, or question.
Orleans-Pobee et al. (2021) studied schizophrenia spectrum disorders (n=16). PACE-Life walking intervention was evaluated on physical activity. The 10-week PACE-Life walking intervention increased self-reported weekly walking minutes and decreased daily sitting hours in 16 individuals with schizophrenia spectrum disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: